Next Article in Journal
Previous Article in Journal
Mar. Drugs 2011, 9(9), 1502-1509; doi:10.3390/md9091502
Article

A New Anthracene Derivative from Marine Streptomyces sp. W007 Exhibiting Highly and Selectively Cytotoxic Activities

1,2
, 3
, 1
, 4
, 1
, 1
, 5
 and 1,*
Received: 12 July 2011; in revised form: 17 August 2011 / Accepted: 19 August 2011 / Published: 9 September 2011
View Full-Text   |   Download PDF [197 KB, uploaded 9 September 2011]
Abstract: A new anthracene derivative, 3-hydroxy-1-keto-3-methyl-8-methoxy-1,2,3,4-tetrahydro-benz[α]anthracene, was isolated from the marine strain Streptomyces sp. W007, and its structure was established by spectroscopic analysis including mass spectra, 1D- and 2D-NMR (1H–1H COSY, HMBC, HSQC and NOESY) experiments. 3-hydroxy-1-keto-3-methyl-8-methoxy-1,2,3,4-tetrahydro-benz[α]anthracene showed cytotoxicity against human lung adenocarcinoma cell line A549.
Keywords: Streptomyces; anthracene; structure establishment; cytotoxicity Streptomyces; anthracene; structure establishment; cytotoxicity
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Zhang, H.; Wang, H.; Cui, H.; Li, Z.; Xie, Z.; Pu, Y.; Li, F.; Qin, S. A New Anthracene Derivative from Marine Streptomyces sp. W007 Exhibiting Highly and Selectively Cytotoxic Activities. Mar. Drugs 2011, 9, 1502-1509.

AMA Style

Zhang H, Wang H, Cui H, Li Z, Xie Z, Pu Y, Li F, Qin S. A New Anthracene Derivative from Marine Streptomyces sp. W007 Exhibiting Highly and Selectively Cytotoxic Activities. Marine Drugs. 2011; 9(9):1502-1509.

Chicago/Turabian Style

Zhang, Hongyu; Wang, Hongpeng; Cui, Hongli; Li, Zonggang; Xie, Zeping; Pu, Yang; Li, Fuchao; Qin, Song. 2011. "A New Anthracene Derivative from Marine Streptomyces sp. W007 Exhibiting Highly and Selectively Cytotoxic Activities." Mar. Drugs 9, no. 9: 1502-1509.



Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert